Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma

Although the receptor tyrosine kinase (RTK) MET is widely expressed in head and neck squamous cell carcinoma (HNSCC), its prognostic value remains unclear. This might be due to the use of a variety of antibodies and scoring systems. Here, the reliability of five commercial C-terminal MET antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: De Herdt, Maria J., Willems, Stefan M., van der Steen, Berdine, Noorlag, Rob, Verhoef, Esther I., van Leenders, Geert J.L.H., van Es, Robert J.J., Koljenović, Senada, de Jong, Robert J. Baatenburg, Looijenga, Leendert H.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914349/
https://www.ncbi.nlm.nih.gov/pubmed/26909606
http://dx.doi.org/10.18632/oncotarget.7534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914349/
https://www.ncbi.nlm.nih.gov/pubmed/26909606
http://dx.doi.org/10.18632/oncotarget.7534

Ejemplares similares